Akari Therapeutics PLC (AKTX)
1.36
-0.11
(-7.48%)
USD |
NASDAQ |
May 03, 16:00
1.30
-0.06
(-4.41%)
After-Hours: 07:51
Akari Therapeutics Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
June 30, 2022 | -5.68M |
March 31, 2022 | -5.176M |
December 31, 2021 | -5.788M |
September 30, 2021 | -1.451M |
June 30, 2021 | -4.346M |
March 31, 2021 | -5.838M |
December 31, 2020 | -6.810M |
September 30, 2020 | 0.9135M |
June 30, 2020 | -7.440M |
March 31, 2020 | -3.745M |
December 31, 2019 | -7.618M |
September 30, 2019 | -2.565M |
June 30, 2019 | -4.117M |
March 31, 2019 | -2.545M |
December 31, 2018 | -7.545M |
September 30, 2018 | -3.593M |
June 30, 2018 | -8.022M |
Date | Value |
---|---|
March 31, 2018 | -1.339M |
December 31, 2017 | -12.12M |
September 30, 2017 | -10.38M |
June 30, 2017 | -0.32M |
March 31, 2017 | -12.58M |
December 31, 2016 | -8.286M |
September 30, 2016 | -0.4181M |
June 30, 2016 | -6.451M |
March 31, 2016 | -2.985M |
December 31, 2015 | 6.472M |
September 30, 2015 | -48.74M |
June 30, 2015 | -1.341M |
March 31, 2015 | -1.697M |
December 31, 2014 | -1.114M |
September 30, 2014 | -0.2231M |
June 30, 2014 | -2.229M |
March 31, 2014 | -1.74M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-7.618M
Minimum
Dec 2019
0.9135M
Maximum
Sep 2020
-4.590M
Average
-5.176M
Median
Mar 2022
Net Income (Quarterly) Benchmarks
DBV Technologies SA | -11.19M |
Cellectis SA | -42.86M |
Adaptimmune Therapeutics PLC | -47.92M |
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | -9.507M |
Net Income (Quarterly) Related Metrics
Enterprise Value | 6.931M |
Earnings Yield | -150.3% |